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Abstract
Background: Health-related quality of life (HRQoL) and return to work are important outcomes in critical care
medicine, reaching beyond mortality. Little is known on factors predictive of HRQoL and return to work in critical
illness, including the acute respiratory distress syndrome (ARDS), and no evidence exists on the role of quality of
care (QoC) for outcomes in survivors of ARDS. It is the aim of the DACAPO study (“Surviving ARDS: the influence of
QoC and individual patient characteristics on quality of life”) to investigate the role of QoC and individual patient
characteristics on quality of life and return to work.
Methods/Design: A prospective, observational, multi-centre patient cohort study will be performed in Germany,
using hospitals from the “ARDS Network Germany” as the main recruiting centres. It is envisaged to recruit 2400
patients into the DACAPO study and to analyse a study population of 1500 survivors. They will be followed up until
12 months after discharge from hospital. QoC will be assessed as process quality, structural quality and volume at the
institutional level. The main outcomes (HRQoL and return to work) will be assessed by self-report questionnaires. Further
data collection includes general medical and ARDS-related characteristics of patients as well as sociodemographic and
psycho-social parameters. Multilevel hierarchical modelling will be performed to analyse the effects of QoC and
individual patient characteristics on outcomes, taking the cluster structure of the data into account.
Discussion: By obtaining comprehensive data at patient and hospital level using a prospective multi-centre
design, the DACAPO-study is the first study investigating the influence of QoC on individual outcomes of ARDS
survivors.
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Background
Health-related quality of life (HRQoL) and return to
work are important outcomes in critical care medicine,
reaching beyond mortality. Little is known on factors
predictive of HRQoL and return to work in critical ill-
ness, including the acute respiratory distress syndrome
(ARDS), and no evidence exists on the role of quality of
care (QoC) for outcomes in survivors of ARDS.
The acute respiratory distress syndrome (ARDS) is a
life threatening condition and is associated with signifi-
cant morbidity and mortality up to 45 % [1]. ARDS is
characterized by respiratory failure, caused either by
direct pulmonary (e.g. pneumonia, aspiration) or indir-
ect extra-pulmonary conditions (e.g. sepsis, massive
transfusion) [2] and requires intensive medical care and
implicit invasive mechanical ventilation.
During the last decades, much clinical research has
been conducted on the management of patients with
ARDS in intensive care units (ICUs). This body of re-
search has focused primarily on the use of optimal ven-
tilation strategies [3], pharmacological therapies [4] and
the improvement of supportive strategies [5]. However,
despite current treatment options in-hospital mortality
in patients suffering from ARDS remains high [1, 6]. At
the same time, the perspective on patients’ long-term
functioning and HRQoL after ARDS has been growing
in importance in recent years [7, 8]. Herridge et al.
demonstrated that less than half of patients surviving
ARDS could return to work within one year [9] and
that survivors showed a decreased HRQoL and were
substantially impaired in physical functioning even after
5 years [10].
Research on predictors of long-term outcomes in sur-
vivors of ARDS is quite scarce and the results are frag-
mentary. Up to now there is some evidence that higher
social status and the availability of social support might
be associated with better medium term health status
[11, 12], whilst the increased prevalence of psychiatric
symptoms represents a factor affecting HRQoL nega-
tively [13]. One important aspect that is likely to deter-
mine outcomes in ARDS is the QoC that patients
receive after developing the syndrome. In the different
phases of the curative and rehabilitative treatment of
ARDS the patients have to pass through various institu-
tions of the health care system: i) intensive care treat-
ment of the primary hospital referring the patient to a
specialized ICU if the patient is not admitted directly to
a highly specialized ICU, ii) inter-hospital transport
from the referring to the specialized hospital, iii) in-
tensive care treatment in the specialized hospital, iv)
the rehabilitation unit. Scientific research investigat-
ing the impact of the health care provided in the
different phases of ARDS treatment has not yet been
conducted.
Aim of the study and hypotheses
The DACAPO study aims at identifying predictive fac-
tors of HRQoL in survivors of ARDS in relation to QoC
delivered in different phases and individual medical and
psycho-social patient characteristics (“DACAPO: Surviv-
ing ARDS: the influence of quality of care and individual
patient characteristics on quality of life”).
The primary hypothesis of the DACAPO study states
that better QoC is associated with higher HRQoL and
higher rates of return to work among patients who sur-
vive an ARDS. Secondary hypotheses are related to po-
tential moderators between QoC and HRQoL: gender,
socio-economic status, social support and psychopatho-
logical syndromes. Being female, having higher socio-
economic status, the availability of higher levels of social
support and not being affected by psychopathological
syndromes should attenuate the associations between
QoC, and HRQoL and return to work, respectively.
Additional research questions refer to the costs of the




DACAPO is an observational, prospective multi-centre
patient cohort study. The study design is depicted in
Fig. 1. Patients will be included in the study at the begin-
ning of their ICU stay in a participating hospital (t0) and
survivors will be followed over a period of 12 months
after discharge from ICU. If patients have been treated
before in a referring hospital, a retrospective assessment
of their health status during their stay in this hospital
and during inter-hospital transport will be performed.
Four follow-up measurements (at discharge from ICU as
well as 3, 6 and 12 months after discharge) will be per-
formed on individual patient level.
Sample & recruitment
Study sites
All 67 hospitals of the “ARDS Network Germany” (hos-
pitals which are specialized in the treatment of patients
with ARDS [14]) are invited to participate in the study.
To ensure that the sample of participating hospitals is
representative hospitals that do not belong to the ARDS
network but provide care for patients with ARDS are
also invited to participate.
Patients
The inclusion criteria for enrolment of patients are mech-
anical ventilation, PaO2/FiO2 (ratio of partial pressure arter-
ial oxygen (PaO2) and fraction of inspired oxygen (Fi02)) <
300 mmHg, and meeting the diagnostic criteria of the
Berlin-definition [15]: i) Acute onset within one week, ii) bi-
lateral pulmonary infiltrates (chest imaging), iii) respiratory
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failure not fully explained by cardiac failure or fluid
overload. Further inclusion criteria are the patient be-
ing treated in any of the participating study sites and
being 18 years old or older. Both female and male pa-
tients are being studied. In order to reflect the reality
of health care delivery in ARDS, no exclusion criteria
are applied.
Sample size and patient flow
Studies on the incidence of ARDS report rates from 13
to 59 cases per 100.000 person-years [16]. Accordingly,
for Germany the incidence could be estimated to be ap-
proximately 40.000 cases per year. Current data from
the “ARDS Network Germany” lead to the assumption
of approximately 40–50 cases per year per hospital.
The estimated patient flow is depicted in Fig. 2. It is
envisaged to screen 2600 patients for the presence of
ARDS and to include 2400 patients as members of the
source population (40–50 cases per year, with approx. 50
participating hospitals from the network resulting in
2000 to 2500 patients). Hospitals from outside the net-
work will also contribute to the recruitment of patients.
However, most of them are of modest or small size and
they are not expected to include a substantial number of
participants (5 to 10 patients each).
In-hospital mortality is assumed to be 30 %. Further,
there will be some patients who will decline participa-
tion in the study, even if their carers had provided pre-
liminary consent. Therefore, we expect to analyse a
study population of 1500 patients at t1 (discharge from
ICU). For each follow-up-assessment (t2-t4: 3 months,
6 months, 12 months after discharge), loss-to-follow-up
due to death, withdrawal of consent or other reasons is
estimated to be about 10 % [17], resulting in slightly
more than 1000 patients at 12-months-follow-up.
Measurements
Data will be captured at the individual patient level as
well as at the level of the health care institutions.
The main predictor is QoC provided in the ICUs of
the participating hospitals. In order to consider different
domains of QoC the following main indicators were
chosen: qualification of physicians (structural quality),
implementation of routine daily multiprofessional ward
rounds with documentation of daily therapy goals
(process quality), number of ventilated patients per year
(volume), and membership of the hospital in the “ARDS
Network Germany” (general characteristics).
A wide range of additional indicators of QoC will be
assessed for the ICUs of the participating hospitals, the
ICUs of the referring hospitals, inter-hospital transporta-
tion, and rehabilitation units. Table 1 gives an overview
on the different indicators organized by institution and
domain. This information will allow for a comprehensive
description of QoC in the different health care institu-
tions which are involved in the care of patients with
ARDS. Additional analyses will explore the associations
between different indicators of QoC and patients’ out-
comes in detail.
As to date there are no agreed quality indicators for
the treatment of patients suffering from ARDS, the se-
lection of all quality indicators was informed by more
generic recommendations regarding QoC of critically ill
patients. We refer to the German quality indicators in
intensive care medicine [18], the recommendations for
inter-hospital transport by the German Interdisciplinary
Society of Intensive Care Medicine (Deutsche Interdiszi-
plinäre Vereinigung für Intensiv- und Notfallmedizin,
DIVI) [19] and the recommendations regarding structural
quality of rehabilitation centres made by the German
Statutory Pension Insurance and the German Statutory
Health Insurance [20].
Fig. 1 Study design. Note: * T-1 only applies to patients who have been treated in a referring hospital
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All indicators will be assessed by questionnaire at the
institutional level.
Main outcome measures of the DACAPO study are
HRQoL and return to work among survivors of ARDS.
HRQoL will be assessed by the Short Form-12 self-
report questionnaire (SF-12) [21]. It comprises twelve
items which are scored according to published algo-
rithms [22]. A physical and a mental component sum-
mary score can be derived, with higher values indicating
higher HRQoL (normalized for the general population
resulting in a standard score with mean = 50 and stand-
ard deviation = 10).
Return to work is operationalized by items represent-
ing two dimensions of survivors’ employment situation:
i) date and ii) extent of return to work (same employ-
ment as before experiencing an ARDS, limitations due
to ARDS-related disabilities, incapable of working).
Moderating variables are gender, socio-economic sta-
tus (SES), prevalent and incident psychopathological
symptoms and the availability of social support.
Gender and SES will be assessed as part of patients’
general characteristics. SES will be operationalized in
two different ways: by the highest educational and pro-
fessional level obtained by participants and by their sub-
jective social status. The MacArthur-Scale assesses the
subjective social status by asking people to place them-
selves on the scales of a ladder according to their per-
ceived social position in their community [23].
The assessment of psychopathological symptoms fo-
cuses on affective disorders (major depression, panic
disorder, post-traumatic stress disorder (PTSD)) and al-
cohol abuse. The validated German version [24, 25] of
the Patient Health Questionnaire (PHQ) [26] is used to
screen for the presence of a major depressive syndrome,
a panic disorder syndrome, and an alcohol abuse syn-
drome. The instrument has been developed as a modu-
lar screening tool to establish provisional diagnoses
according to DSM-IV (Diagnostic and Statistical Manual
of Mental Disorders) [27]. The PTSS-14 (Post-Traumatic
Stress Syndrome 14-Questions Inventory) [28] (German
version: [29]) is employed to assess the prevalence of
symptoms suggestive of PTSD, such as intrusions, avoid-
ance behaviour or heightened irritability. The inventory
has been adapted to traumata elicited by the experience
Enrolment
Follow-up 
at month 0: t1
Assessed for eligibility 
at admission to ICU (t0)
(n= 2600)
Excluded  (n= 700)
♦ death during ICU or withdrawal of   
consent (n=700)
♦ high extent of missing data or other 
reason (n=200)
Inlcuded into the study population
and analyzed at t1
(n= 1500)
Lost to follow-up at 3 months: 10%
Lost to follow-up at 6 months: 10%
Lost to follow-up at 12 months: 10%
♦ death
♦ withdrawal of consent
♦ other reason
Follow-up 
at month 12: t4 
Not eligible  (n= 200)
♦ Not meeting inclusion criteria
♦ Declined to participate




Fig. 2 Expected patient flow
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of an ICU stay. Four items assess potential traumatic ex-
periences during ICU in order to distinguish between
ICU acquired and preexisting PTSD.
Social support will be assessed using the F-SozU K-14
[30]. The questionnaire covers three distinctive domains
of social support (emotional support, instrumental sup-
port, social integration). The 14 items are scored on a 5-
point Likert scale, with higher values indicating higher
levels of social support.
In order to provide a comprehensive description of the
study population and to account for potential confounding
variables, additional information is assessed at the level of
the individual patient. This comprises general medical ICU
parameters (e.g. comorbidity, prognostic scores (SAPS
Table 1 Overview on data at the institutional level




level of care level of care
teaching status teaching status teaching status
specialization of the ICU specialization of the ICU specialization
member of the ARDS network

































daily multiprofessional ward rounds with





daily multiprofessional ward rounds







monitoring of sedation, analgesia and
delirium
monitoring of sedation, analgesia and
delirium
use of a nursing
documentation system
lung protective ventilation lung protective ventilation implementation of
treatment pathways
daily spontaneous breathing trials daily spontaneous breathing trials internal quality
management
documentation of structured caregiver-
communication





hand disinfection consumption hand disinfection consumption
implementation of treatment pathways
in accordance with up-to-date
recommen-dations (e.g. early enteral
nutrition, non-invasive ventilation)
implementation of treatment pathways
in accordance with up-to-date
recommen-dations (e.g. early enteral
nutrition, non-invasive ventilation)
Volume number of patients per year number of patients per year number of patients
per year




number of patients died within 24 h
per year
number of patients died within 24 h
per year
Notes: aData on inter-hospital transport is assessed at the individual patient level; however, it refers to the institutional level as it represents characteristics of
quality of health care. bold: variables of main interest
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(Simplified Acute Physiology Score) II, SAPS III [31, 32])),
an organ dysfunction score (SOFA (Sequential Organ
Failure Assessment score [33])), parameters relating to
ARDS (e.g. cause and severity) and its treatment (e.g.
ventilation parameters, use of supportive care mea-
sures, critical events (hypoglycaemia, hypoxia)) as well
as socio-demographic and psycho-social characteristics.
All parameters and their operationalization are listed in
Table 2.
Additionally, costs will be assessed as direct costs in
terms of treatment costs at the ICU.
The selection of measurements for the DACAPO
study was driven by the scientific literature on HRQoL
of survivors of ARDS and potential influential factors as
well as by the expertise of collaborators from a wide
range of disciplinary backgrounds.
Data sources and data collection
A wide range of data sources and assessment methods will
be used. Particular emphasis is being put on the use of
routine data (e.g. data from patients’ health records) in
order to minimize workload for the participating hospitals
and to reduce the burden which additional diagnostic pro-
cedures and clinical evaluations might impose upon the
patients and their carers.
Patients’ general medical characteristics and medical data
relating to ARDS and its treatment will be assessed during
ICU stay and gathered through electronic case report forms
(eCRFs). Staff of the participating hospitals (physicians,
study nurses) is being trained with regard to eCRF data
entry. Most data will be extracted from ongoing documen-
tations and patients’ health records, some data will have to
be specifically assessed for the purpose of the study.
Table 2 Overview on data at the individual patient level: constructs and operationalizations
Constructs/concepts Score/instrument
Socio-demographic characteristics age, gender
living situation, presence of informal caregiver(s), marital status
nationality
educational and professional level, employment
subjective social status MacArthur-Scale [23]
General medical characteristics height, weight, waist circumference
history of smoking, current smoking
comorbidity according to SAPS III [32]
history of psychiatric disorders
Medical characteristics relating to ARDS
and its treatment
cause and severity of ARDS according to the “Berlin-
Definition” [15]
prognostic scores at ICU admission SAPS II [31], SAPS III [32]
organ dysfunction/failure SOFA [33]
blood gas analysis
ventilation parameters
presence of delirium CAM-ICU, RASS [41]
treatment with supportive care measures: ECMO, NO-inhalation,
prone-positioning, muscle relaxant medication, tracheotomy
complications
length of ICU stay
Characteristics of health institution use length of hospital stay before referral to specialized centre, duration of
inter-hospital transport, length and type of rehabilitative measures
outpatient health-service use
Psycho-social characteristics prevalence of psychopathological syndromes: major depressive
syndrome, panic syndrome, PTSD, alcohol abuse
PHQ [26], PTSS-14 [28, 29]
disability Barthel-Index of Activities of Daily
Living [42, 43]
social support F-SOZU [30]
healthrelated quality of life SF-12 [21]
return to work
Notes: bold: moderators and main outcomes
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Data on the direct costs of treating patients with
ARDS in the ICU will be gathered from hospital records
as well. In Germany all hospitals are obliged to provide
data on each patient’s medical treatments and proce-
dures for the purpose of cost planning and statistics to
the German Hospital Federation (German Hospital Fees
Act, Krankenhausentgeltgesetz [34]). These data will be
requested for the patients included in the study.
A 12-months mortality follow-up will be performed.
Local municipal population registries will be contacted
to obtain data on mortality at the patient level.
At baseline, caregivers will provide proxy report of pa-
tients’ socio-demographic data, at follow-ups (discharge
from ICU, 3 months, 6 months, 12 months), patients them-
selves will complete self-report questionnaires on socio-
demographic and psycho-social characteristics as well as on
the main outcome measures. Questionnaires will be sent
out by post. If they are not sent back within a period of four
weeks, patients will be reminded by mail and phone. All at-
tempts to contact patients will be documented.
Data on general hospital characteristics will be ob-
tained from the generally accessible quality reports of
German hospitals [35]. Data on indicators of QoC will
be assessed through questionnaires administered to the
directors of the hospitals/ICUs.
Data management
With numerous hospitals participating in the DACAPO
study, a web-based system for data entry seems to be
most suitable. The open source software OpenClinica,
version 3.1, will be used for electronic data collection
and data management [36].
The IT center at the University of Regensburg will host
the webserver for the OpenClinica instance. The web-based
system has a secure communication protocol (https) with a
digital certificate of SSL (=Secure Sockets Layer), as well as
a reverse proxy as an additional security measure. The ser-
ver will be updated frequently and backups will be per-
formed daily.
eCRFs will be used for data entry. By enabling verifica-
tion rules and edit checks, data entry persons will receive
immediate feedback while the data are being entered into
the system. In addition, queries can be deployed to valid-
ate missing or incomplete data or implausible values so
that the supplied data remain consistent across all hospi-
tals and high data quality is achieved. Furthermore, a con-
tinuous assessment of data quality will be performed by
exporting data sets to statistical packages to run further
error and plausibility checks.
Data from paper-pencil-questionnaires completed by
patients will be entered into the database twice in order
to ensure high data quality.
Personal data of participating patients will be strictly
separated from the study data. Each participating patient
will have an identification number for the study data and
a separate identification number for his/her personal data.
Both identifiers are pseudonymized. Only the trust office
of the DACAPO study center is authorized to have access
to the personal data of the enrolled patients. The data
management is restricted solely to the study data. This
separation is required in order to fulfill data protection
guidelines.
Statistical analysis
The analytical principles and statistical techniques to
be employed in order to address the main aim of the
DACAPO study (to identify the influence of QoC on
survivors’ HRQoL and return to work) are as follows:
The selection of participating hospitals implies consid-
erable baseline differences between the treated patients.
To control for individual patient characteristics which
might confound the relationship between QoC and the
main outcomes, a wide range of variables are assessed.
Using univariate analyses (χ2, T, Pearson’s r2), all of them
will be checked for a potential confounding effect. Vari-
ables which are significantly related to predictor or out-
comes in univariate analyses, will be included in the
regression models.
The data resulting from the DACAPO study are orga-
nized in a hierarchical structure. While outcomes and
potential confounders at the patient level (level 1) will
vary between the patients, this does not apply to the pre-
dictor variables (QoC) at hospital level (level 2) which
will be the same for all patients treated in a given hos-
pital. This violates the statistical assumption of the inde-
pendence of observations (i.e. measurements of patients
within a hospital are more likely resembling each other
than measurements of patients from different hospitals),
resulting in an underestimation of standard errors by or-
dinary nonhierarchical regression models. Thus, multi-
level modelling will be applied, a technique which allows
to account for the grouping of patients into higher order
clusters (hospitals). The modelling procedure will be car-
ried out in three steps: i) A fully unconditional model
not including level 1 and level 2 predictors will be fitted
in order to determine the influence of the context (treat-
ment in a given hospital) on outcome (HRQoL/return to
work). The resulting intraclass correlation coefficient
(ICC) describes the proportion of variance in the out-
come variable explained by context. ii) Individual patient
characteristics will be added to the model (fixed effects
at level 1). iii) Context characteristics (QoC indicator of
interest in each hospital) will be added to the model
(fixed effects at level 2). The final model will allow for
evaluating the effect sizes and the statistical significance of
the influences of QoC and of individual patient-related
variables on outcomes while considering the clustered
structure of the data.
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A linear multilevel regression model will be fitted
both for the physical and the mental component sum-
mary score of the SF-12. A non-parametric multilevel
regression model will be used for the outcome “return
to work”.
The modelling procedure will be applied to each of
the operationalizations of the predictor “QoC”. This ap-
proach will result in twelve final models (4 operationali-
zations of the predictor × 3 main outcomes). Thus, it
will be crucial to consider the overall consistency of the
associations as basis for the interpretation of the results
and the decision about the hypothesis.
A power analysis has not been performed as all pa-
tients at participating study sites should be screened for
eligibility.
All analyses will be carried out using SAS 9.4 software
[37] and STATA version 12 software [38].
Ethics and consent
The study has been approved by the ethic committee of
the University of Regensburg (original approval: Decem-
ber 2013, approval of an amendment: June 2014; file
number 13-101-0262) and by ethic committees of par-
ticipating study centres. Due to the characteristics of
ARDS and its treatment in the ICU (mechanical ventila-
tion, analgosedation) the majority of patients will not be
able to provide informed consent at the time of enrol-
ment in the study. For the time period during which the
patient is incapable of providing informed consent, pa-
tients’ caregivers or legal guardians will provide informed
consent. Once the patient will be capable of providing
informed consent he or she will be asked to confirm or
disapprove the consent of the caregiver and to provide
informed consent on his/her own.
Governance
The study is jointly led by TB and CA (principal investiga-
tors) and has an independent advisory board composed of
four experts from the fields of epidemiology, medical soci-
ology, anaesthesiology and pneumology. Authorship for
the research papers emerging from the DACAPO study
will be assigned according to the recommendations of the
International Committee of Medical Journal Editors [39].
Representatives of all centres that contribute patients to
the study will be jointly named the “DACAPO study
group” and will be acknowledged as such in each scientific
paper emerging from the study.
Discussion
The specification of an adequate study-design, an appro-
priate operationalization and a suitable statistical analysis
with regard to the research questions of the DACAPO
study, results in some inherent challenges arising from
conceptual as well as from practical specifics:
It is assumed that efficacious and effective treatment and
care of patients is facilitated by a high extent and quality of
intersectoral collaboration between different health care in-
stitutions and health care professionals, whilst a lack of the
former is made responsible for the provision of non-
optimal treatment. This applies particularly to patients with
long-lasting and complex conditions who pass through
various health service institutions over the course of illness
and recovery, as is expected to be the case for patients with
ARDS. However, this fragmentation of the health care sys-
tem and the assumed lack of collaboration do not only
affect the treatment and care of patients but also the feasi-
bility of research involving different health care institutions.
Experiences made during the preparatory work for the
DACAPO study suggest that professionals from the health
care sectors responsible for in-hospital treatment and re-
habilitation might not be well informed about their mutual
practices regarding the care of patients with ARDS.
The DACAPO study aims to assess QoC within all
health care institutions involved in the treatment of pa-
tients with ARDS. However, there is a lack of evidence-
based quality measures which can be applied. Beyond,
there are not even any established and consented guide-
lines on what good care of ARDS is and which specific
interventions should be performed [5]. Thus, we use in-
dicators of more general aspects of QoC (QoC in the
ICU, QoC in rehabilitation units) which might not com-
pletely capture the specific features relevant for assessing
the QoC provided for patients with ARDS.
Patients suffering from ARDS are study participants
who are not capable of providing informed consent. Their
caregivers need to consent to the participation in the
study in lieu of the patients while they witness a life-
threatening condition of a family member. This situation
demands sympathetical and comprehensive information
of patients’ caregivers provided through the medical pro-
fessionals and may, nevertheless, result in lower participa-
tion rates. It is, therefore, particularly crucial to minimize
loss-to-follow-up due to withdrawal of consent or failed
attempts to contact participants. Otherwise, there might
be concerns regarding the validity of the study results. A
recent study described in detail the efforts made to gather
follow-up measurements of patients surviving ARDS and
strengthens the importance of repeated attempts to con-
tact participants [40]. In order to assess attrition bias, we
will perform a drop-out analysis, by comparing socio-
demographic characteristics of those who drop out with
those who will have complete follow-up data.
The output expected from the DACAPO study is as fol-
lows: By obtaining comprehensive data at patient and hos-
pital level using a prospective multi-centre design, the
DACAPO study will be the first study investigating the
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influence of QoC on individual outcomes of ARDS survi-
vors. The envisaged sample size allows for complex ana-
lyses while considering potential moderating variables and
confounders. No exclusion criteria will be applied. Thus,
findings from this study are expected to have high external
validity and therefore enable important insights into the
real provision of health care services to patients suffering
from ARDS in Germany. We expect to identify potential
weaknesses in the treatment of patients with ARDS, par-
ticularly regarding the different involved health care insti-
tutions. Having uncovered these, further studies might
target them and contribute to an improvement in the treat-
ment of ARDS.
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